Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to evaluate the safety and efficacy of vagus nerve stimulation (VNS) for treating Alzheimer's disease (AD) in patients aged 50-80 years with mild cognitive impairmen...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Beijing Municipal Administration of Hospitals
NCT07234695 · Down Syndrome, Down Syndrome (DS), and more
NCT07213349 · Alzheimer Disease (AD)
NCT07146412 · Cognitive Impairment, Alzheimer Blood Biomarkers, and more
NCT07526480 · Alzheimer Disease (AD), Mild Cognitive Impairment (MCI), and more
NCT07237958 · Alzheimer Disease (AD), Dementia Alzheimer Type, and more
Beijing Tiantan Hospital
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions